Literature DB >> 4430718

Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast.

E C LeRoy.   

Abstract

Cultures of dividing skin fibroblasts from normal and sclerodermatous human skin have permitted estimations of soluble collagen concentration, net collagen accumulation, cell-doubling times, and the comparison of morphologic and ultrastructural characteristics. In vitro, the scleroderma fibroblast produces more soluble collagen, synthesizes collagen more rapidly, and fourfold more of its protein synthetic activity is directed to collagen production than in the normal skin fibroblast. Cell-doubling times and morphologic and ultrastructural observations of cells in culture have not provided clues to the nature of the biologic defect in the regulation or activation of collagen synthesis by the scleroderma fibroblast.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4430718      PMCID: PMC301627          DOI: 10.1172/JCI107827

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Increased protocollagen proline hydroxylase activity in sclerodermatous skin.

Authors:  H R Keiser; H D Stein; A Sjoerdsma
Journal:  Arch Dermatol       Date:  1971-07

2.  Scleroderma and the subcutaneous tissue.

Authors:  R Fleischmajer; V Damiano; A Nedwich
Journal:  Science       Date:  1971-03-12       Impact factor: 47.728

3.  Direct measurement of the rate of collagen synthesis in skin.

Authors:  H R Keiser; A Sjoerdsma
Journal:  Clin Chim Acta       Date:  1969-02       Impact factor: 3.786

4.  Scleroderma: dermal amino acid composition with particular reference to hydroxyproline.

Authors:  K H Neldner; J D Jones; R K Winkelmann
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

5.  Chemical synthesis of the dermis in scleroderma.

Authors:  R Fleischmajer; S Krol
Journal:  Proc Soc Exp Biol Med       Date:  1967-10

6.  A modified procedure for radioactive hydroxyproline assay in urine and tissues after labeled proline administration.

Authors:  E C LeRoy; E D Harris; A Sjoerdsma
Journal:  Anal Biochem       Date:  1966-12       Impact factor: 3.365

7.  Solubility of skin collagen in normal human subjects and in patients with generalised scleroderma.

Authors:  J Uitto; K Ohlenschläger; I Lorenzen
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

8.  The ultrastructure of skin in progressive systemic sclerosis (scleroderma). I. Dermal collagen fibers.

Authors:  R L Hayes; G P Rodnan
Journal:  Am J Pathol       Date:  1971-06       Impact factor: 4.307

9.  The nature of the collagen synthesized by cultured human fibroblasts.

Authors:  D L Layman; E B McGoodwin; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

10.  Protocollagen proline hydroxylase activity in the skin of normal human subjects and of patients with scleroderma.

Authors:  J Uitto; J Halme; M Hannuksela; P Peltokallio; K I Kivirikko
Journal:  Scand J Clin Lab Invest       Date:  1969-05       Impact factor: 1.713

View more
  99 in total

Review 1.  Bone marrow transplantation in the treatment of systemic sclerosis.

Authors:  F Viganego; R Nash; D E Furst
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 2.  The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide.

Authors:  S J Oliver
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

3.  Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Authors:  Y Kawaguchi; M Hara; T M Wright
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 4.  Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis.

Authors:  B Eckes; D Kessler; M Aumailley; T Krieg
Journal:  Springer Semin Immunopathol       Date:  1999

5.  Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.

Authors:  Pei-Suen Tsou; Nadine N Talia; Adam J Pinney; Ann Kendzicky; Sonsoles Piera-Velazquez; Sergio A Jimenez; James R Seibold; Kristine Phillips; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2011-12-12

Review 6.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

7.  Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis.

Authors:  Camilo S Zurita-Salinas; Edgar Krötzsch; Lino Díaz de León; Jorge Alcocer-Varela
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

Review 8.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

9.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

Review 10.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.